A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Antiviral Activity of Multiple Doses of HH-006 Injection in Untreated Chronic Hepatitis B Virus Infected Individuals
Latest Information Update: 14 Apr 2026
At a glance
- Drugs HH 006 (Primary)
- Indications Chronic hepatitis
- Focus Adverse reactions
- Sponsors Huahui Health
Most Recent Events
- 14 Apr 2026 New trial record